Drug Shortage Report for SODIUM CHLORIDE INJECTION USP
Report ID | 182674 |
Drug Identification Number | 00037842 |
Brand name | SODIUM CHLORIDE INJECTION USP |
Common or Proper name | Sodium Chloride Injection USP |
Company Name | ICU MEDICAL CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM CHLORIDE |
Strength(s) | 9MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 100 mL (4:1) |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-01-30 |
Estimated end date | 2023-02-13 |
Actual end date | 2023-02-24 |
Shortage status | Resolved |
Updated date | 2023-02-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2600 BOUL ALFRED-NOBEL, SUITE 100 SAINT LAURENT, QUEBEC CANADA H4S 0A9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2023-02-25 | English | Compare |
v5 | 2023-02-24 | French | Compare |
v4 | 2023-02-24 | English | Compare |
v3 | 2023-01-31 | English | Compare |
v2 | 2023-01-30 | French | Compare |
v1 | 2023-01-30 | English | Compare |
Showing 1 to 6 of 6